Top States
Dharma Pharmaceuticals Top StatesApr 2026
Top states where Dharma Pharmaceuticals is active based on indexed sales coverage.
Is this your Brand? Log in to Hoodie!
Apr 2026
YoY growth plummeted 71.0% for DHARMA PHARMACEUTICALS, which now holds a premium price tier. In just three months, sales have dropped 54.7%, reflecting a significant downward trend in consumer interest.
Categories
Top States
Top states where Dharma Pharmaceuticals is active based on indexed sales coverage.
Trend View
24-Month Trend

Average Price
$83.01
YoY Sales Trend
71.0%
2Y Sales Trend
66.8%
Edibles dominate with 79.9% of sales, skyrocketing 494.7% YoY. In stark contrast, Flower sales have cratered by 97.7% YoY, underscoring a dramatic shift in consumer preferences.
| Category | Sales Share | Avg Price | YoY |
|---|---|---|---|
| Edibles | 80.1% | $90.97 | 494.7% |
| Concentrates | 11.5% | $75.2 | 85.0% |
| Flower | 4.3% | $100.87 | 97.7% |
| Topicals | 2.8% | $43.63 | 63.1% |
Trend View
24-Month Trend

Average Price
$83.01
YoY Sales Trend
71.0%
2Y Sales Trend
66.8%
Category Breakout
| Category | Sales Share | Avg Price | YoY |
|---|---|---|---|
| Edibles | 80.1% | $90.97 | 494.7% |
| Concentrates | 11.5% | $75.2 | 85.0% |
| Flower | 4.3% | $100.87 | 97.7% |
| Topicals | 2.8% | $43.63 | 63.1% |
State Rank Table
| State | Edibles | Concentrates | Flower | Topicals |
|---|---|---|---|---|
| Virginia | 4 | 5 | 12 | 3 |
Virginia is the sole market for DHARMA PHARMACEUTICALS, accounting for 100% of sales. This geographic concentration highlights a critical focus area for growth.
| State | Edibles | Concentrates | Flower | Topicals |
|---|---|---|---|---|
| 4 | 5 | 12 | 3 |
Market Position
Competitive summary unavailable.
SKU View
Top products for Apr 2026 with sales and momentum indicators.
| Product | Category | MoM |
|---|---|---|
#1 | Edibles | 139.2% |
#2 | Edibles | 1.1% |
#3 | Edibles | N/A |
#4 | Edibles | 10.4% |
#5 | Edibles | 61.5% |
#6 | Concentrates | 54.8% |
#7 | Concentrates | 8.3% |
Benchmarking
Peer brands benchmarked against Dharma Pharmaceuticals using competitive landscape rank coverage, proximity, and momentum.